Supplements

Regulations are anything but complementary

Guest voice

Regulations are anything but complementary

By Dr Wendy Morrow, executive director, Complementary Healthcare Council of Australia

Something is not right when regulators increasingly opt to assess complementary medicines against medical criteria—in much the same way as pharmaceutical drugs are assessed. 

Mixed vitamin E forms show liver benefits: Rat data

Mixed vitamin E forms show liver benefits: Rat data

By Stephen Daniells

A mixture of vitamin E tocotrienols and alpha-tocopherol may work synergistically to improve liver health in lab animals with non-alcoholic steatohepatits (NASH), the most extreme form of non-alcoholic fatty liver disease (NAFLD).

Japanese firm seeks EU probiotic approval

Japanese firm seeks EU probiotic approval

By Jane Joseph

The UK Food Standards Agency (FSA) is calling for views on an application from Japan’s Miyarisan Pharmaceutical for European Union Novel Foods status for a probiotic strain.

PS supplements show ADHD benefits in children: RCT data

PS supplements show ADHD benefits in children: RCT data

By Stephen DANIELLS

Children with attention-deficit hyperactivity disorder (ADHD) may benefit from daily supplements of phosphatidylserine (PS), according to a new study from an international team of researchers.

How high can high-end omega-3 go?

Special edition: Omega-3 (Editor's blog)

How high can high-end omega-3 go?

By Shane STARLING

Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.

Ayurvedic workhorses poised for market breakthrough, expert predicts

Ayurvedic workhorses poised for market breakthrough, expert predicts

By Hank Schultz

If you are looking for what’s hot on the botanical front in 2013, here’s the skinny from a longtime observer of the herbal arena: Open your lesson book to the first two pages, and follow after me: A is for Ayurveda and ashwagandha and B is for bacopa.

Does CLA boost bone health for men?

Does CLA boost bone health for men?

By Stephen DANIELLS

Long-term intakes of conjugated linoleic acid (CLA) may be associated with bone strength in men, says a new study from Canada and Australia, but the conclusions have been questioned by a leading CLA supplier.

Breast milk probiotic launched in Australia

World first: Breast milk probiotic launched in Australia

By Shane Starling

Spanish supplier Biosearch Life is finding success with its patented, immune system-boosting and mastitis battling probiotic isolated from human breast milk in a world-first product launched in Australia this year.

Neptune and Aker facing off in court yet again

Krill wars

Neptune and Aker facing off in court yet again

By RJ Whitehead

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now announced that it filed opposition to an Aker patent application earlier...

Evolva pays €550,000 for Fluxome resveratrol business

Evolva pays €550,000 for Fluxome resveratrol business

By Shane Starling

Swiss biotech firm Evolva has bought failing Fluxome’s, yeast-derived resveratrol business for about €550,000 in cash and shares, but says it has no interest in the remaining omega-3 business being sold by sealed auction.

DSM buys Fortitech for €495m; “We are done for awhile”

DSM buys Fortitech for €495m; “We are done for awhile”

By Shane Starling

Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient blending giant, Fortitech (€212m/$270m annual turnover).

Q3 wrap: Nutrition stars for DSM and Naturex

Q3 wrap: Nutrition stars for DSM and Naturex

By Shane Starling

Royal DSM saw Q3 sales slip 7% to €2.3bn across all divisions with polymer intermediates performing worst, but as has been the case in recent quarters, the Dutch firm’s nutrition cluster held firm with 1% organic growth in difficult economic times.

Asian krill boom drives krill joint venture

Asian krill boom drives krill joint venture

By Shane Starling

Australian, Japanese, South Korean, Taiwanese and other Asian consumers are driving rising demand in omega-3 source krill to levels that have prompted Norwegian krill supplier, Rimfrost, to ink a production-boosting joint venture.

Dr Rajeshwar Smarta: “This dialogue forms a process of trust.

Peering into Asia's health claim progression

By RJ Whitehead

In a freewheeling panel discussion during the second afternoon of the Vitafoods Asia nutraceuticals and supplements show, regulations in food and packaging claims came under the spotlight.